The prevalence of anemia in chronic heart failure.

[1]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[2]  R. Carmel,et al.  Anemia and aging: an overview of clinical, diagnostic and biological issues. , 2001, Blood reviews.

[3]  D. Schwartz,et al.  The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. , 2001, Clinical nephrology.

[4]  D. Silverberg,et al.  The pathological consequences of anaemia. , 2001, Clinical and laboratory haematology.

[5]  P. Mohacsi,et al.  Serum erythropoietin in heart failure patients treated with ACE‐inhibitors or AT1 antagonists , 2000, European journal of heart failure.

[6]  D. Smith,et al.  Anemia in the elderly. , 2000, American family physician.

[7]  David B. Wyck,et al.  Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapy , 2000 .

[8]  G. London,et al.  Pathophysiology of anaemia: focus on the heart and blood vessels. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[10]  A. Bergner,et al.  Angiotensin-II, Renal Anemia and Hyporesponsiveness to Recombinant Human Erythropoietin , 1999, The International journal of artificial organs.

[11]  A. Collins,et al.  Hematocrit levels and hospitalization risks in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[12]  A. Collins,et al.  Hematocrit level and associated mortality in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[13]  D. Marcelli,et al.  Nephrology Dialysis Transplantation the Impact of Haematocrit Levels and Erythropoietin Treatment on Overall and Cardiovascular Mortality and Morbidity—the Experience of the Lombardy Dialysis Registry Selected the Live Patients on Dialysis Treatment On , 2022 .

[14]  P. Kaufmann,et al.  [Anemia and heart function]. , 1997, Praxis.

[15]  T. Nakata,et al.  Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease. , 1997, The Canadian journal of cardiology.

[16]  B. Wikström,et al.  Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease. , 1996, Scandinavian journal of urology and nephrology.

[17]  P. Poole‐Wilson,et al.  Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. , 1993, British heart journal.

[18]  M. Brennan,et al.  Follow-up [2] , 1992 .

[19]  F. Pentimone,et al.  [Clinical evaluation of anemia in the aged]. , 1992, Minerva medica.

[20]  W. März,et al.  Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. , 1991, American journal of nephrology.

[21]  I. Macdougall,et al.  Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin , 1990, The Lancet.

[22]  N. Tatsumi,et al.  [Reticulocyte counts in the aged]. , 1989, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[23]  P. Stander.  Anemia in the elderly. Symptoms, causes, and therapies. , 1989, Postgraduate medicine.

[24]  P. Grützmacher,et al.  Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. , 1989, Clinical nephrology.

[25]  R. Howe.  Anemia in the elderly: Common causes and suggested diagnostic approach , 1983 .

[26]  W. Bablok,et al.  A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.